SAN DIEGO--(BUSINESS WIRE)--Accelrys, Inc. (NASDAQ:ACCL), a leading provider of scientific business intelligence solutions, announced the release of Discovery Studio® 2.0, the most advanced modeling and simulation software environment for drug discovery available today. The new release features a fully integrated work environment for life science researchers allowing them to go from project conception to lead optimization using a diverse set of sophisticated software applications in a single, easy-to-use environment. Because it is built upon SciTegic® Pipeline Pilot™, Accelrys’ scientific operating platform, Discovery Studio 2.0 is an extensible virtual discovery environment that lets researchers integrate any tool they need to create solutions that are uniquely tailored to fit their research process.
